메뉴 건너뛰기




Volumn 93, Issue 11, 1998, Pages 2106-2112

Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for helicobacter pylori eradication in duodenal ulcer disease: Results of three multicenter, double-blind, united states trials

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE; PLACEBO; UREASE;

EID: 0032460579     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00602.x     Document Type: Article
Times cited : (73)

References (14)
  • 1
    • 0031896344 scopus 로고    scopus 로고
    • U.S. double-blind, controlled trials of omeprazole and amoxicillin for treatment of H. pylori
    • Laine L., Johnson E., Suchower L., et al. U.S. double-blind, controlled trials of omeprazole and amoxicillin for treatment of H. pylori. Aliment Pharmacol Ther. 12:1998;377-382.
    • (1998) Aliment Pharmacol Ther , vol.12 , pp. 377-382
    • Laine, L.1    Johnson, E.2    Suchower, L.3
  • 2
    • 0030775973 scopus 로고    scopus 로고
    • What are the treatment goals for Helicobacter pylori infection
    • Fennerty M.B. What are the treatment goals for Helicobacter pylori infection. Gastroenterology. 113:1997;S120-S125.
    • (1997) Gastroenterology , vol.113
    • Fennerty, M.B.1
  • 3
    • 0030731496 scopus 로고    scopus 로고
    • What other treatment regimens are under investigation to treat Helicobacter pylori infection
    • Unge P. What other treatment regimens are under investigation to treat Helicobacter pylori infection. Gastroenterology. 113:1997;S131-S148.
    • (1997) Gastroenterology , vol.113
    • Unge, P.1
  • 4
    • 0001043167 scopus 로고    scopus 로고
    • How do clinicians in the U.S. manage Helicobacter pylori-related gastrointestinal diseases? A comparison of primary care and specialist physicians
    • Breuer T., Goodman K.J., Malaty H.M., et al. How do clinicians in the U.S. manage Helicobacter pylori-related gastrointestinal diseases? A comparison of primary care and specialist physicians. Am J Gastroenterol. 93:1998;553-561.
    • (1998) Am J Gastroenterol , vol.93 , pp. 553-561
    • Breuer, T.1    Goodman, K.J.2    Malaty, H.M.3
  • 5
    • 0030223132 scopus 로고    scopus 로고
    • Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH 1 Study
    • Lind T., van Zanten S.J.O.V., Unge P., et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials the MACH 1 Study . Helicobacter. 1:1996;138-144.
    • (1996) Helicobacter , vol.1 , pp. 138-144
    • Lind, T.1    Van Zanten, S.J.O.V.2    Unge, P.3
  • 6
    • 0030611919 scopus 로고    scopus 로고
    • A United States multicentre trial of dual and proton pump inhibitior-based triple therapies for Helicobacter pylori
    • Laine L., Frantz J.E., Baker A., Neil G.A. A United States multicentre trial of dual and proton pump inhibitior-based triple therapies for Helicobacter pylori. Aliment Pharmacol Ther. 11:1997;913-917.
    • (1997) Aliment Pharmacol Ther , vol.11 , pp. 913-917
    • Laine, L.1    Frantz, J.E.2    Baker, A.3    Neil, G.A.4
  • 7
    • 0030016498 scopus 로고    scopus 로고
    • One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection
    • Yousfi M.M., El-Zimaity, Cole R.A., et al. One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 10:1996;617.
    • (1996) Aliment Pharmacol Ther , vol.10 , pp. 617
    • Yousfi, M.M.1    El-Zimaity2    Cole, R.A.3
  • 8
    • 0030308983 scopus 로고    scopus 로고
    • Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: A short report
    • Schwartz H., Krause R., Siepman N., et al. Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection a short report . Helicobacter. 1:1996;251-255.
    • (1996) Helicobacter , vol.1 , pp. 251-255
    • Schwartz, H.1    Krause, R.2    Siepman, N.3
  • 9
    • 0029820444 scopus 로고    scopus 로고
    • Randomized comparison of differing periods of twice-a-day therapy for the eradication of Helicobacter pylori
    • Laine L., Estrada R., Trujillo M., et al. Randomized comparison of differing periods of twice-a-day therapy for the eradication of Helicobacter pylori. Aliment Pharmacol Ther. 10:1996;1029-1033.
    • (1996) Aliment Pharmacol Ther , vol.10 , pp. 1029-1033
    • Laine, L.1    Estrada, R.2    Trujillo, M.3
  • 10
    • 0003298571 scopus 로고    scopus 로고
    • The MACH 2 study: Optimal Helicobacter pylori therapy need omeprazole and can be reliably assessed by UBT
    • (abstract)
    • Lind T., Bardhan K.D., Bayerdorffer E., et al. The MACH 2 study optimal Helicobacter pylori therapy need omeprazole and can be reliably assessed by UBT . Gastroenterology. 112:1997;A200. (abstract).
    • (1997) Gastroenterology , vol.112 , pp. 200
    • Lind, T.1    Bardhan, K.D.2    Bayerdorffer, E.3
  • 11
    • 0001229082 scopus 로고    scopus 로고
    • In vitro susceptibility of pre-treatment isolates of Helicobacter pylori from two multicenter United States clinical trials
    • (abstract)
    • Weissfeld A.S., Simmons D.E., Vance P.H., et al. In vitro susceptibility of pre-treatment isolates of Helicobacter pylori from two multicenter United States clinical trials. Gastroenterology. 110:1996;A295. (abstract).
    • (1996) Gastroenterology , vol.110 , pp. 295
    • Weissfeld, A.S.1    Simmons, D.E.2    Vance, P.H.3
  • 12
    • 0008325246 scopus 로고    scopus 로고
    • One week low-dose triple therapy for eradication of H. pylori: A large multicentre, randomised trial
    • (abstract)
    • Misiewicz J.J., Harris A.W., Bardhan K.D., et al. One week low-dose triple therapy for eradication of H. pylori: a large multicentre, randomised trial. Gastroenterology. 110:1996;A198. (abstract).
    • (1996) Gastroenterology , vol.110 , pp. 198
    • Misiewicz, J.J.1    Harris, A.W.2    Bardhan, K.D.3
  • 13
    • 0030830693 scopus 로고    scopus 로고
    • The Report on the Digestive Health Initiative International Update Conference on Helicobacter pylori. Gastroenterology. 113:1997;S4-S8.
    • (1997) Gastroenterology , vol.113
  • 14
    • 0032563694 scopus 로고    scopus 로고
    • A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori
    • Fennerty M.B., Kovacs T.O.G., Krause R., et al. A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori. Arch Intern Med. 158:1998;1651-1656.
    • (1998) Arch Intern Med , vol.158 , pp. 1651-1656
    • Fennerty, M.B.1    Kovacs, T.O.G.2    Krause, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.